Perez, Jocelyn D.

HRN: 24-70-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
04/10/2024
04/16/2024
IVTT
500 Mg
OD
Sepsis, Cap Hr, Infected Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: